D. P. Abhushan Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Parenteral Drugs (India) Limited has informed the Exchange regarding Resignation of Ms Suruchi Maheshwari as Company Secretary & Compliance Officer of the company w.e.f. January 01, 2022.
Tembo Global Industries Limited has informed the Exchange regarding Sub: Disclosure in pursuance Non Applicability of SEBI Circular no. SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018 - with respect to fund raising by issuance of debt securities SYMBOL: TEMBO ISIN- INE869Y01010 With reference to SEBI Circular mentioned in caption in the matter of fund raising by issuance of Debt securities by Large Entities, specifically mandating certain disclosure to the exchange by the listed entity (viz. Large Corporate-LC) as mentioned in paragraph 4 of the circular no. SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018, fulfilling the criteria specified in paragraph 2.2 of the same circular. We would like to inform that Tembo Global Industries Limited is not falling under Large Corporate (LC) category as per the framework provided in the circular as mention below:- 1.have no specified securities or debt securities or non-convertible redeemable preference share, listed on any recognised
Salasar Techno Engineering Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Superhouse Limited has informed the Exchange about Loss of Share Certificates
Bajaj Consumer Care Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
India Grid Trust has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Accuracy Shipping Limited with respect to announcement dated 29-Dec-2021, regarding amendment to the object clause of Memorandum of Association of a Company. On basis of above the Company was required to clarify following: 1. Amendments to Memorandum and/or Articles of association of listed entity, in brief. The response of the Company is attached.
Venus Remedies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.